RNF212
Probable E3 SUMO-protein ligase RNF212
Also known as: FLJ38841, LOC285498, RN212_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q495C1
- Gene
- RNF212
- Ensembl
- ENSG00000178222
- Chromosome
- 4
- Canonical length
- 297 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins
OverviewNCBI Gene
This gene encodes a RING finger protein that may function as a ubiquitin ligase. The encoded protein may be involved in meiotic recombination. This gene is located within a linkage disequilibrium block and polymorphisms in this gene may influence recombination rates. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Oct 2010]
Canonical amino-acid sequenceUniProt
297 residues, UniProt reviewed canonical sequence.
>Q495C1|RNF212
1 MANWVFCNRC FQPPHRTSCF SLTNCGHVYC DACLGKGKKN ECLICKAPCR TVLLSKHTDA
61 DIQAFFMSID SLCKKYSRET SQILEFQEKH RKRLLAFYRE KISRLEESLR KSVLQIEQLQ
121 SMRSSQQTAF STIKSSVSTK PHGCLLPPHS SAPDRLESME VDLSPSPIRK SEIAAGPARI
181 SMISPPQDGR MGPHLTASFC FIPWLTLSKP PVPGECVISR GSPCFCIDVC PHWLLLLAFS
241 SGRHGELTNS KTLPIYAEVQ RAVLFPFQQA EGTLDTFRTP AVSVVFPLCQ FERKKSFLocalizationUniProt · AlphaFold · HPA
Whether an antibody against RNF212 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.59
- Highest tissue expression
- 8.5 nTPM
Expression across tissuesHPA
Tissue
- pancreas: 8.5 nTPM
- pituitary gland: 6.9 nTPM
- ovary: 4.8 nTPM
- testis: 4.5 nTPM
- kidney: 4.3 nTPM
- thyroid gland: 4.2 nTPM
Single-cell type
- oocytes: 74 nCPM
- early primary spermatocytes: 71 nCPM
- lactotrophs: 68 nCPM
- somatotrophs: 49 nCPM
- undifferentiated spermatogonia: 46 nCPM
- differentiating spermatogonia: 42 nCPM
Immune cell
- naive CD4 T-cell: 2.4 nTPM
- memory CD4 T-cell: 1.7 nTPM
- naive B-cell: 1 nTPM
- T-reg: 1 nTPM
- gdT-cell: 0.9 nTPM
- MAIT T-cell: 0.7 nTPM
Brain region
- cerebellum: 11 nTPM
- basal ganglia: 5.6 nTPM
- choroid plexus: 4.5 nTPM
- amygdala: 4.3 nTPM
- white matter: 4.3 nTPM
- cerebral cortex: 4.2 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about RNF212.
Disease | AllUniProt
Conditions RNF212 is implicated in, by any mechanism.
- Spermatogenic failure 62 (SPGF62) MIM:619673
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 79 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Spermatogenic failure 62
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.86
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.07
- DepMap mean gene effect
- 0.1
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- chiasma assembly
- homologous chromosome pairing at meiosis
- meiotic gene conversion
- protein sumoylation
- reciprocal meiotic recombination
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RNF212 as an antibody target. Whether an autoantibody or antibody against RNF212 could matter depends on whether native RNF212 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RNF212 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label RNF212 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...